Not Waiting to Progress; How the COVID-19 Pandemic Nudged Neoadjuvant Therapy for Stage III Locally Advanced Melanoma Patients

Background: Early-phase neoadjuvant trials have demonstrated promising results in the utility of upfront immunotherapy in locally advanced stage III melanoma and unresected nodal disease. Secondary to these results and the COVID-19 pandemic, this patient population, traditionally managed through sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinaschuk, Katie, Cheng, Tina, Brenn, Thomas, McKinnon, J. Gregory, Temple-Oberle, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217267/
https://www.ncbi.nlm.nih.gov/pubmed/37232793
http://dx.doi.org/10.3390/curroncol30050335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217267/
https://www.ncbi.nlm.nih.gov/pubmed/37232793
http://dx.doi.org/10.3390/curroncol30050335

Ejemplares similares